glp-1 drugs moa Mechanism of action of agonists – My Endo Consult Discovery of GLP-1–Based Drugs for
Description
Lilly's oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine [press release]
Screening for eating disorders before prescribing the drugs may help, but no national guidelines require physicians to do somost professional groups only recommend it
C., Edmondson, S., Feeney, W
The drug doesnt work better if you inject it in the stomach vs
CVOTs primarily proved cardiovascular safety and tolerability of different GLP-1 receptor agonists, but also showed cardiovascular benefit of specific drugs
